Benckiser

RBGLY Investors Urged to Step Forward in Class-Action Lawsuit Against Reckitt Benckiser Group Over Alleged Securities Fraud

by

Investors in Reckitt Benckiser Group PLC are presented with the opportunity to take a leading role in a securities fraud lawsuit against the British multinational consumer goods company. Based in Slough, England, Reckitt Benckiser has come under scrutiny as concerns mount over alleged misleading statements to investors regarding its financial performance. The controversy revolves around potential inaccuracies in the company’s reporting and the implications of those figures on investor decisions. Legal experts note that shareholders can significantly influence the direction of the lawsuit by joining together in this action against the company. The outcome could … Read more

Reckitt Benckiser Stock Plunges 15% as Jury Awards $60 Million in Damages Over Enfamil Baby Formula

by

BELLEVILLE, Ill. – Reckitt Benckiser Group Plc, a UK consumer goods company, experienced a sharp decline in stock prices following a court ruling that awarded $60 million in damages to an Illinois woman. The jury determined that the company’s Enfamil baby formula played a role in the death of her premature baby. This case marks the first of its kind to proceed to trial in the United States. The verdict caused a 15% drop in Reckitt Benckiser Group’s stock, resulting in the company’s lowest level in a decade. This decline wiped out approximately £5.4 billion … Read more

Abbott and Reckitt Benckiser Clash in Court: $60M Verdict Over Enfamil Baby Formula

by

NORTH CHICAGO, ILLINOIS – Abbott Laboratories saw a decline in its stock price on Friday following a jury verdict in an Illinois state court. The jury ordered rival company Reckitt Benckiser’s Mead Johnson unit to pay $60 million over allegations that a premature child died after consuming the company’s Enfamil baby formula. This verdict represents the first trial outcome among the hundreds of lawsuits filed against both Reckitt Benckiser and Abbott, all claiming that their baby formulas caused a gastrointestinal disease called necrotizing enterocolitis (NEC) in children. Abbott’s stock dropped approximately 4% after the news, … Read more

Reckitt Benckiser Group Plc Faces Historic Blow as Enfamil Baby Formula Verdict Shakes Stock Market

by

(Chicago, Illinois) Consumer goods company Reckitt Benckiser Group Plc saw a drastic 15% drop in its stock following a jury’s decision to award an Illinois woman $60 million in damages. The verdict, which came in the first trial of its kind in the United States, stated that Reckitt Benckiser’s Enfamil baby formula was responsible for the death of the woman’s premature baby. This significant blow resulted in the company’s stock closing at its lowest level in a decade, erasing a staggering £5.4 billion ($6.9 billion) in market value. The ruling carries considerable implications for Reckitt … Read more